• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于韩国急性心肌梗死注册研究(KAMIR),根据非 ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗的时机对预后进行评估。

Prognosis according to the timing of percutaneous coronary intervention in non-ST segment elevation myocardial infarction, based on the Korean Acute Myocardial Infarction Registry (KAMIR).

机构信息

Division of Cardiology, Department of Internal Medicine, College of Medicine, Pusan National University, 10 Ami-dong 1-ga Seo-gu, Busan, Korea.

出版信息

Cardiol J. 2011;18(4):421-9.

PMID:21769823
Abstract

BACKGROUND

Patients with acute coronary syndrome without ST-segment elevation (ACS- -NSTE) are at risk for adverse cardiac events. Based on data in the Korean Acute Myocardial Infarction Registry (KAMIR), we analyzed the prognosis according to the timing of percutaneous coronary intervention (PCI) in patients with NSTEMI in Korea.

METHODS AND RESULTS

2,455 patients with NSTEMI in KAMIR were classified according to the time interval from the onset of cardiac symptoms to PCI. Patients in Group I underwent PCI within 24 hours of the onset of symptoms; in Group II between 24 and 48 hours; and in Group III after 48 hours. Major adverse cardiac events (MACEs) are defined as cardiac death, non-cardiac death, myocardial infarction, revascularization and coronary-artery bypass graft surgery. The MACEs were compared between groups. Of the 2,455 patients, 743 (30.2%) were assigned to Group I, 583 (23.7%) to Group II, and 1,129 (45.9%) to Group III. The total incidence of MACEs was higher in Group I than Group III, and similar between Groups I and II (Group I: 15.1%, Group II: 14.4%, Group III: 11.6%, p = 0.053). The incidence of MACEs in the intermediate TIMI risk score group had decreased as the intervention time was delayed.

CONCLUSIONS

The prognosis according to the timing of PCI in patients with NSTEMI was similar based on the data in KAMIR. TIMI risk score was related to a high incidence of MACEs.

摘要

背景

无 ST 段抬高的急性冠状动脉综合征(ACS-NSTE)患者存在不良心脏事件风险。基于韩国急性心肌梗死注册研究(KAMIR)的数据,我们分析了韩国 NSTEMI 患者经皮冠状动脉介入治疗(PCI)时机与预后的关系。

方法和结果

KAMIR 中 2455 例 NSTEMI 患者根据从心脏症状发作到 PCI 的时间间隔进行分类。第 I 组患者在症状发作后 24 小时内行 PCI;第 II 组在 24 至 48 小时内行 PCI;第 III 组在 48 小时后行 PCI。主要不良心脏事件(MACE)定义为心脏性死亡、非心脏性死亡、心肌梗死、血运重建和冠状动脉旁路移植术。比较各组之间的 MACE。2455 例患者中,743 例(30.2%)分入第 I 组,583 例(23.7%)分入第 II 组,1129 例(45.9%)分入第 III 组。第 I 组的 MACE 总发生率高于第 III 组,与第 II 组无差异(第 I 组:15.1%,第 II 组:14.4%,第 III 组:11.6%,p=0.053)。随着干预时间的延迟,中间 TIMI 风险评分组的 MACE 发生率下降。

结论

基于 KAMIR 数据,NSTEMI 患者 PCI 时机与预后相似。TIMI 风险评分与 MACE 发生率高相关。

相似文献

1
Prognosis according to the timing of percutaneous coronary intervention in non-ST segment elevation myocardial infarction, based on the Korean Acute Myocardial Infarction Registry (KAMIR).基于韩国急性心肌梗死注册研究(KAMIR),根据非 ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗的时机对预后进行评估。
Cardiol J. 2011;18(4):421-9.
2
Prognostic impact of significant non-infarct-related left main coronary artery disease in patients with acute myocardial infarction who receive a culprit-lesion percutaneous coronary intervention.接受罪犯病变经皮冠状动脉介入治疗的急性心肌梗死患者中,显著的非梗死相关左主干冠状动脉疾病的预后影响。
Coron Artery Dis. 2012 Aug;23(5):307-14. doi: 10.1097/MCA.0b013e3283519f25.
3
Management patterns of non-ST segment elevation acute coronary syndromes in relation to prior coronary revascularization.非 ST 段抬高型急性冠状动脉综合征与既往冠状动脉血运重建相关的管理模式。
Am Heart J. 2010 Jan;159(1):40-6. doi: 10.1016/j.ahj.2009.09.019.
4
Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.大剂量阿托伐他汀在 ST 段抬高型心肌梗死患者直接经皮冠状动脉介入治疗前的疗效:STIN 试验。
JACC Cardiovasc Interv. 2010 Mar;3(3):332-9. doi: 10.1016/j.jcin.2009.11.021.
5
Optimal Timing of Percutaneous Coronary Intervention in Patients With Non-ST-Segment Elevation Myocardial Infarction Complicated by Acute Decompensated Heart Failure (from the Korea Acute Myocardial Infarction Registry-National Institutes of Health [KAMIR-NIH]).非ST段抬高型心肌梗死合并急性失代偿性心力衰竭患者经皮冠状动脉介入治疗的最佳时机(来自韩国急性心肌梗死注册研究-美国国立卫生研究院[KAMIR-NIH])
Am J Cardiol. 2018 Jun 1;121(11):1285-1292. doi: 10.1016/j.amjcard.2018.01.051. Epub 2018 Mar 1.
6
Clinical outcomes after PCI for acute coronary syndrome in unprotected left main coronary artery disease: insights from the Swiss Acute Left Main Coronary Vessel Percutaneous Management (SALVage) study.经皮冠状动脉介入治疗(PCI)治疗无保护左主干冠状动脉疾病急性冠状动脉综合征的临床结局:来自瑞士急性左主干冠状动脉血管经皮管理(SALVage)研究的结果。
EuroIntervention. 2011 Oct 30;7(6):697-704. doi: 10.4244/EIJV7I6A112.
7
The impact of unsuccessful percutaneous coronary intervention on short- and long-term prognosis in STEMI and NSTEMI.经皮冠状动脉介入治疗失败对 STEMI 和 NSTEMI 患者短期和长期预后的影响。
Catheter Cardiovasc Interv. 2011 Oct 1;78(4):514-22. doi: 10.1002/ccd.22727. Epub 2011 May 27.
8
Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.经皮冠状动脉介入治疗治疗的前冠状动脉旁路移植术患者伴 ST 段抬高型心肌梗死。
JACC Cardiovasc Interv. 2010 Mar;3(3):343-51. doi: 10.1016/j.jcin.2009.12.008.
9
What is optimal revascularization strategy in patients with multivessel coronary artery disease in non-ST-elevation myocardial infarction? Multivessel or culprit-only revascularization.非 ST 段抬高型心肌梗死患者多支血管病变的最佳血运重建策略是什么?多支血管病变血运重建或罪犯血管血运重建。
Int J Cardiol. 2011 Dec 1;153(2):148-53. doi: 10.1016/j.ijcard.2010.08.044. Epub 2010 Sep 16.
10
Long-term outcomes after invasive management for older patients with non-ST-segment elevation myocardial infarction.老年非ST段抬高型心肌梗死患者侵入性治疗后的长期预后
Circ Cardiovasc Qual Outcomes. 2013 May 1;6(3):323-32. doi: 10.1161/CIRCOUTCOMES.113.000120. Epub 2013 May 7.

引用本文的文献

1
Effect of different revascularization times on intermediate-risk non-ST-elevation acute coronary syndrome.不同血运重建时间对中危非 ST 段抬高型急性冠状动脉综合征的影响。
Sci Rep. 2022 Sep 20;12(1):15714. doi: 10.1038/s41598-022-20185-9.
2
Implementation of National Health Policy for the Prevention and Control of Cardiovascular Disease in South Korea: Regional-Local Cardio-Cerebrovascular Center and Nationwide Registry.韩国国家心血管疾病预防与控制卫生政策的实施:地区-地方心脑血管中心与全国登记系统
Korean Circ J. 2021 May;51(5):383-398. doi: 10.4070/kcj.2021.0001.
3
Biomarker for the Prediction of Major Adverse Cardiac Events in Patients with Non-ST-Segment Elevation Myocardial Infarction.
非ST段抬高型心肌梗死患者主要不良心脏事件预测的生物标志物
Osong Public Health Res Perspect. 2017 Aug;8(4):237-246. doi: 10.24171/j.phrp.2017.8.4.02. Epub 2017 Aug 31.